Gepatofit

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT HEPATOPHYT

Composition:

Active substances: 1 package (50 g) contains a mixture of medicinal plant raw materials: bean pods (Phaseoli fructus (sine semine)) 6 g, dandelion roots (Taraxaci officinalis radix) 6 g, sand everlasting flowers (Helichrysi arenarii flos) 6 g, rosehip fruits (Rosaepseudo-fructus) 6 g, corn stigmas with styles (Zea mays styli cum stigmatis) 5.5 g, marigold flowers (Calendulae flos) 5.5 g, goat's rue herb (Galegae herba) 5 g, nettle leaves (Urticae folium) 5 g, milk thistle fruits (Silybi mariani fructus) 5 g.

Pharmaceutical form. Herbal mixture.

Main physico-chemical characteristics: mixture of pieces of various shapes, grayish-green in color, with reddish-brown, yellow and white inclusions. Odor pleasant.

Pharmaco-therapeutic group.

Agents used in liver and biliary tract disorders.

ATC code A05.

Pharmacological properties.

Pharmacodynamics.

HEPATOFIT promotes restoration of liver cells (hepatocytes), improves hepatic detoxification function, enhances bile secretion, reduces the tone of the gallbladder and biliary tract, increases bile acid concentration and decreases cholesterol concentration. It moderately supports reduction of blood glucose levels.

Clinical characteristics.

Indications. As part of complex therapy for liver and biliary tract diseases (chronic hepatitis, chronic cholecystitis, cholangitis, hypotonic-type biliary dyskinesia); as part of complex therapy for diabetes mellitus.

Contraindications. Grade III arterial hypertension, obstructive jaundice, cholelithiasis with presence of stones larger than 10 mm in diameter, hypoglycemia, acute viral hepatitis, thrombophlebitis, increased blood coagulation, acute poisonings of various etiologies; hypersensitivity to any component of the medicinal product or to other plants of the daisy family (Compositae/Asteraceae).

Special precautions. Should be used with caution in patients with peptic ulcer disease of the stomach and duodenum in the stage of exacerbation, liver cirrhosis, acute hepatitis, acute cholecystitis, and acute pancreatitis; as well as in chronic pancreatitis or enterocolitis during the exacerbation phase.

Interaction with other medicinal products and other types of interactions. Not established.

Special precautions.

Use during pregnancy or breastfeeding. There are no data on the safety and efficacy of the drug during pregnancy or breastfeeding; therefore, it should not be used during these periods.

Ability to affect reaction speed when driving or operating machinery. The medicinal product does not affect the ability to drive or operate machinery; however, patients with vestibular disorders should exercise caution until their individual response is determined.

Dosage and Administration.

Steep 2 tablespoons of the herbal mixture in 500 ml of boiling water, keep covered for 1 hour, then strain.

For adults and children aged 7 years and older, take warm, ⅔ cup (150 ml) 20–30 minutes before meals, three times daily.

Duration of use should be determined by a physician. Usually, the treatment course does not exceed 4 weeks. If necessary, the course may be repeated upon a physician's recommendation.

Children. The preparation is contraindicated for children under 7 years of age.

Overdose. May result in increased intensity of adverse reactions.

Adverse reactions.

The medicinal product is generally well tolerated by patients. However, due to its multi-component composition, allergic reactions may occur, mostly in cases of individual hypersensitivity to any of the components or in case of violation of the recommended dosage regimen, including:

Gastrointestinal system: nausea, vomiting, dyspepsia, heartburn, mild diarrhea;

Respiratory system: dyspnea;

Urinary system: increased diuresis;

Skin: allergic reactions, including pruritus, hyperemia, skin swelling;

Other: exacerbation of pre-existing vestibular disorders.

If any adverse reactions occur, it is necessary to consult a physician.

Shelf life. 2 years. Do not use after the expiry date stated on the packaging.

Storage conditions. In the original packaging at a temperature not exceeding 25 °C, in a place inaccessible to children.

Packaging. 50 g per sachet, placed in a carton.

Availability. Over-the-counter.

Manufacturer. LLC "Scientific and Production Pharmaceutical Company "EYM".

Manufacturer's address and place of business. Ukraine, 61091, Kharkiv region, Kharkiv, st. Kharkivs'kykh Dyviziï, 20, lit. "A-5".

Date of last review.

Approved

Order of the Ministry of Health

of Ukraine

_________________ № _______

Registration Certificate

№ UA/3550/01/01

INSTRUCTIONS

for medical use of the medicinal product

HEPATOPHYT

Composition:

Active ingredients: 1 package (100 g) contains a mixture of medicinal plant raw materials: bean pods (Phaseoli fructus (sine semine)) 12 g, dandelion roots (Taraxaci officinalis radix) 12 g, everlasting flowers (Helichrysi arenarii flos) 12 g, rosehip fruits (Rosaepseudo-fructus) 12 g, corn stigmas with styles (Zea mays stigma cum stylis) 11 g, marigold flowers (Calendulae flos) 11 g, goat's rue herb (Galegae herba) 10 g, nettle leaves (Urticae folium) 10 g, milk thistle fruits (Silybi mariani fructus) 10 g.

Pharmaceutical form. Herbal mixture.

Main physicochemical characteristics: a mixture of greyish-green fragments of various shapes with reddish-brown, yellow, and white inclusions. Pleasant odor.

Pharmacotherapeutic group.

Agents used in liver and biliary tract disorders.

ATC code A05.

Pharmacological Properties.

Pharmacodynamics.

HEPATO FIT promotes the restoration of liver cells (hepatocytes), improves the liver's detoxifying function, enhances bile secretion, reduces the tone of the gallbladder and bile ducts, increases the concentration of bile acids and decreases cholesterol concentration. It moderately supports reduction of blood glucose levels.

Clinical characteristics.

Indications. In combination therapy for liver and biliary tract diseases (chronic hepatitis, chronic cholecystitis, cholangitis, hypotonic-type biliary dyskinesia); in combination therapy for diabetes mellitus.

Contraindications. Grade III arterial hypertension, obstructive jaundice, cholelithiasis with presence of stones larger than 10 mm in diameter, hypoglycemia, acute viral hepatitis, thrombophlebitis, increased blood coagulation, acute poisonings of various etiologies; hypersensitivity to any component of the medicinal product or to other plants of the aster family (Compositae/Asteraceae).

Special precautions. Should be used with caution in patients with peptic ulcer disease of the stomach and duodenum in the stage of exacerbation, liver cirrhosis, acute hepatitis, acute cholecystitis, and acute pancreatitis; in chronic pancreatitis or enterocolitis during the phase of exacerbation.

Interaction with other medicinal products and other forms of interaction. Not established.

Special precautions.

Use during pregnancy or breastfeeding. There are no data on the safety and efficacy of the drug during pregnancy or breastfeeding; therefore, it should not be prescribed during these periods.

Ability to affect reaction speed when driving or operating machinery. The medicinal product does not affect the ability to drive or operate machinery; however, patients with vestibular disorders should exercise caution until their individual response is determined.

Method of Administration and Dosage.

Pour 500 ml of boiling water over 2 tablespoons of the herbal mixture, let it steep in a closed container for 1 hour, then strain.

For adults and children aged 7 years and older, take ⅔ of a glass (150 ml) warm, 20–30 minutes before meals, 3 times daily.

The duration of use should be determined by a physician. Usually, the treatment course does not exceed 4 weeks. If necessary, the course may be repeated upon a physician's recommendation.

Children. The preparation is contraindicated for children under 7 years of age.

Overdose. May result in an intensification of adverse reactions.

Adverse reactions.

The medicinal product is generally well tolerated by patients. However, due to its multi-component composition, allergic reactions are possible, mostly in cases of individual hypersensitivity to any of the components or in case of violation of the recommended dosage regimen, including:

Gastrointestinal system: nausea, vomiting, dyspepsia, heartburn, mild diarrhea;

Respiratory system: shortness of breath;

Urinary system: increased diuresis;

Skin: allergic reactions, including itching, hyperemia, skin swelling;

Other: exacerbation of pre-existing vestibular disorders.

In case of any adverse reactions, consult a physician.

Shelf life. 2 years. Do not use after the expiry date stated on the packaging.

Storage conditions. In the original packaging at a temperature not exceeding 25 °C, in a place inaccessible to children.

Packaging. 100 g per sachet, placed in a carton.

Availability category. Over-the-counter.

Manufacturer. LLC "Scientific and Production Pharmaceutical Company "EIM".

Manufacturer's location and address of business activity. 20 lit. "A-5", Kharkivs'kykh Dyviziy Street, Kharkiv, Kharkiv Oblast, 61091, Ukraine.

Date of last review.

Approved

Order of the Ministry of Health

of Ukraine

__________________ № __________

Registration certificate

№ UA/3550/01/01

INSTRUCTION

for medical use of the medicinal product

HEPATOPHYT

Composition:

Active ingredients: 1 filter bag (1.5 g) contains a mixture of herbal raw materials: bean pods (Phaseoli fructus (sine semine)) 180 mg, dandelion roots (Taraxaci officinalis radix) 180 mg, sand everlasting flowers (Helichrysi arenarii flos) 180 mg, rose hips (Rosaepseudo-fructus) 180 mg, corn stigmas with styles (Zea maydis styli cum stigmata) 165 mg, marigold flowers (Calendulae flos) 165 mg, goat's rue herb (Galegae herba) 150 mg, nettle leaves (Urticae folium) 150 mg, milk thistle fruits (Silybi mariani fructus) 150 mg.

Pharmaceutical form. Herbal mixture.

Main physico-chemical properties: a mixture of irregularly shaped fragments of grayish-green color with reddish-brown, yellow, and white inclusions. The odor is pleasant.

Pharmacotherapeutic group.

Agents used in liver and biliary tract disorders.

ATC code A05.

Pharmacological properties.

Pharmacodynamics.

HEPATOFEET promotes the restoration of liver cells (hepatocytes), improves the liver's detoxification function, enhances bile secretion, reduces the tone of the gallbladder and bile ducts, increases the concentration of bile acids, and decreases cholesterol concentration. It moderately supports reduction of blood glucose levels.

Clinical characteristics.

Indications. As part of complex therapy for liver and biliary tract diseases (chronic hepatitis, chronic cholecystitis, cholangitis, hypotonic-type biliary dyskinesia); as part of complex therapy for diabetes mellitus.

Contraindications. Grade III arterial hypertension, obstructive jaundice, cholelithiasis with presence of stones larger than 10 mm in diameter, hypoglycemia, acute viral hepatitis, thrombophlebitis, increased blood coagulation, acute poisonings of various etiologies; hypersensitivity to any component of the drug or to other plants of the aster family (Compositae/Asteraceae).

Special precautions. Should be used with caution in patients with peptic ulcer of stomach and duodenum in the stage of exacerbation, liver cirrhosis, acute hepatitis, acute cholecystitis and acute pancreatitis; in chronic pancreatitis or enterocolitis during exacerbation phase.

Interaction with other medicinal products and other forms of interactions. Not established.

Special precautions.

Use during pregnancy or breastfeeding. There are no data on the safety and efficacy of the drug during pregnancy or breastfeeding; therefore, it should not be prescribed during these periods.

Ability to affect reaction speed when driving or operating machinery. The medicinal product does not affect the ability to drive or operate machinery; however, patients with vestibular disorders should exercise caution until individual response is determined.

Method of administration and dosage.

Pour 150 ml of boiling water over 2 filter packets, let stand in a closed container for 15 minutes.

For adults and children aged 7 years and older, take 150 ml warm, 3 times daily, 20–30 minutes before meals.

The duration of treatment is determined by a physician. Usually, the treatment course does not exceed 4 weeks. If necessary, the course may be repeated upon a physician's recommendation.

Children. The preparation is contraindicated in children under 7 years of age.

Overdose. May result in an intensification of adverse reactions.

Side effects.

The medicinal product is generally well tolerated by patients. However, due to its multi-component composition, allergic reactions may occur, especially in cases of individual hypersensitivity to any of the components or in case of violation of the recommended dosage regimen, including:

Gastrointestinal system: nausea, vomiting, dyspepsia, heartburn, mild diarrhea;

Respiratory system: shortness of breath;

Urinary system: increased diuresis;

Skin: allergic reactions, including itching, hyperemia, skin swelling;

Other: exacerbation of pre-existing vestibular disorders.

In case of any adverse reactions, consult a physician.

Shelf life. 2 years. Do not use after the expiry date stated on the package.

Storage conditions. In the original packaging at a temperature not exceeding 25 °C, in a place inaccessible to children.

Packaging. 1.5 g in filter bags, 20 pcs.

Dispensing category. Over-the-counter.

Manufacturer. LLC "Scientific and Production Pharmaceutical Company "EYM".

Manufacturer's address and place of business. Ukraine, 61091, Kharkiv region, Kharkiv, st. Kharkivskikh Diviziy, 20, lit. "A-5".